Reoperation does not provide a survival advantage in patients with recurrent Glioblastoma treated with irinotecan/bevacizumab treatment
Conclusion: The second surgery in recurrent GBM has limited effect in clinical course.
Source: Indian Journal of Cancer - Category: Cancer & Oncology Authors: Ozlem Nuray Sever Kadir Oktay Ebru G & #252;zel Vildan Kaya Aslan G & #252;zel Mustafa Y & #305;ld & #305;r & #305;m Source Type: research